I think ISX was trying to manage the disclosure in such a way as to minimize any impacts as it was still trying to negotiate a favorable outcome with Visa. In hindsight, if the negotiations had resulted in a favorable outcome, would there have been a need to disclose this to the market?
Moreover, there were sensitive negotiations on-going with potential ISX clients at the time which would have been jeopardized had ISX been running commentary on the dispute with Visa.
ASX on the other hand was bent on finding a smoking gun to justify the continued suspension.
What we shareholders are missing is the complete picture as we can't view all the correspondence between ISX and Visa.
Did Visa actually find any legally valid AML-related concerns (or was it just opinion-based as the ASX's findings) and if so, which regulatory authorities has it been raised with?
There are always different opinions on what exactly the issue was as far as a commercial dispute is concerned. From a legal perspective, on the other hand, there can only be one truthful disclosure I think?